BioNexus Gene Lab Corp. Increase (Decrease) of Restricted Investments
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) of Restricted Investments of -$12.94 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseOfRestrictedInvestments · last filed 2019-05-15
- BioNexus Gene Lab Corp. increase (decrease) of restricted investments for the quarter ending 2018-03-31 was -$12.94K.
| Period end | Increase (Decrease) of Restricted Investments 3 month |
|---|---|
| 2018-03-31 | -$12.94K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |